TransMedics names new CFO and reiterates 2026 revenue guidance
Go back to TransMedics names new CFO and reiterates 2026 revenue guidance| (NASDAQ: TMDX) | Delayed: 85.04 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $85.04 | 52 Week High | $ | |||
| Open | $85.04 | 52 Week Low | $ | |||
| Day High | $85.04 | P/E | N/A | |||
| Day Low | $85.04 | EPS | $ | |||
| Volume | 627 | |||||

